• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR OMNILINK ELITE; PERIPHERAL STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR OMNILINK ELITE; PERIPHERAL STENT DELIVERY SYSTEM Back to Search Results
Catalog Number 11003-29
Device Problems Difficult to Remove (1528); Material Rupture (1546); Material Separation (1562); Improper or Incorrect Procedure or Method (2017)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 11/22/2019
Event Type  Injury  
Manufacturer Narrative
(b)(4).Exemption number e2019001.The device is expected to be returned for investigation.It has not yet been received.A follow-up report will be submitted with all additional relevant information.
 
Event Description
It was reported that the procedure was performed to treat a lesion in the heavily calcified right iliac artery.Pre-dilatation was performed with an unspecified balloon dilatation catheter.An unspecified 6f introducer sheath was used, and, though there was no air aspiration, the 7x29mm omnilink elite 35 stent delivery system (sds) was advanced to the target lesion without resistance.The stent was fully deployed at 11 atmospheres, and the balloon of the sds ruptured.During removal, the balloon felt resistance with the stent and the introducer sheath.Force was applied, and the distal portion of the balloon separated.The separated portion was removed through medical intervention and minor surgery.An unspecified covered stent was used to close the access site created for retrieval of the balloon portion.There was a clinically significant delay in the procedure.No additional information was provided.
 
Manufacturer Narrative
Visual analysis was performed on the return device.The reported balloon rupture and separation were confirmed.The difficulty removing was not confirmed as it was based on procedural circumstances.It should be noted that the omnilink elite instruction for use (ifu), states: should unusual resistance be felt at any time during either vessel / duct access or during removal of an undeployed stent, the stent delivery system and introducer sheath should be removed as a single unit.Additionally, the step of preparation of the pta catheter is listed prior to introduction of the system into the patient in ifu.In this case, the difficulties were most likely related to the anatomical conditions.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other similar incidents and/or complaints from this lot.The investigation determined that that the reported difficulties and subsequent patient effects were due to case circumstances.It is likely that the balloon rupture was the result of interaction with the heavily calcified lesion.Additionally, the resistance during removal and separation was likely the result of the ruptured balloon material catching on the introducer sheath during removal.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OMNILINK ELITE
Type of Device
PERIPHERAL STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key9473128
MDR Text Key174744009
Report Number2024168-2019-14536
Device Sequence Number1
Product Code NIO
Combination Product (y/n)N
PMA/PMN Number
P110043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 02/10/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/16/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/31/2022
Device Catalogue Number11003-29
Device Lot Number9051741
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/16/2019
Date Manufacturer Received01/28/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-